TABLE 2.
Summary of miRNAs involved in the pathogenesis of schistosomiasis.
| MiR-name | Target genes | Pathways | Function | References |
| Let-7b | TβRI | TGF-β/SMAD signaling pathway | Anti-fibrosis | Tang et al., 2017 |
| MiR-21 | SMAD7 | TGF-β/SMAD and IL-13/STAT6 signaling pathways | Pro-fibrosis | Kong et al., 2019 |
| MiR-27b | PPARγ | TGF-β signaling pathway | Pro-fibrosis | Zhu et al., 2018a |
| MiR-92a-2-5p | TLR2 | Unstudied | Anti-fibrosis | Zhao et al., 2019 |
| MiR-96 | SMAD7 | TGF-β/SMAD signaling pathway | Pro-fibrosis | Luo et al., 2018 |
| MiR-130a-3p | MAPK1, TβRI, TβRII | TGF-β and MAPK signaling pathways | Anti-fibrosis | Liu et al., 2021 |
| MiR-146a/b | STAT1 | IFN-γ signaling pathway | Macrophage transformation | He et al., 2016 |
| MiR-155 | FOXO3a | ERK1 signaling pathway | Pro-fibrosis | Zhu et al., 2018b |
| MiR-181a | TLR4 | TLR4 receptor signaling pathway | Anti-fibrosis | Tang et al., 2021 |
| MiR-182 | FOXO1 | PI3K/AKT signaling pathway | Pro-fibrosis | Huang et al., 2018 |
| MiR-200a | TGF-β2 | TGF-β signaling pathway | Anti-fibrosis | Xu et al., 2021 |
| MiR-203-3p | SMAD3 | SMAD signaling pathway | Anti-fibrosis | He et al., 2018b |
| MiR-351 | VDR | SMAD and IFN-γ signaling pathways | Pro-fibrosis | He et al., 2018a |
| MiR-454 | SMAD4 | SMAD signaling pathway | Anti-fibrosis | Zhu et al., 2014 |
| Sja-miR-1 | SFRP1 | Wnt/β-catenin pathway | Pro-fibrosis | Wang Y. et al., 2020 |
| Sja-miR-71a | SEMA4D, FZD4 | TGF-β/SMAD and IL-13/STAT6 signaling pathways | Anti-fibrosis | Wang L. et al., 2020; Jiang et al., 2022 |
| Sja-miR-125b, Sja-bantam | PROS1, FAM212B, CLMP | Unstudied | Macrophage proliferation | Liu et al., 2019 |
| Sja-miR-2162 | TβRIII | TGF-β/SMAD signaling pathway | Pro-inflammatory, Pro-fibrosis | He et al., 2020 |
| Sja-miR-3096 | PIK3C2A | Unstudied | Tumor suppressor | Lin et al., 2019 |